These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30409834)

  • 21. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
    Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of human UDP-glucuronyltransferases on the formation of the methylenedioxymethamphetamine (ecstasy) phase II metabolites R- and S-3-methoxymethamphetamine 4-O-glucuronides.
    Schwaninger AE; Meyer MR; Zapp J; Maurer HH
    Drug Metab Dispos; 2009 Nov; 37(11):2212-20. PubMed ID: 19666989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human UDP-glucuronosyltransferase isoforms involved in bisphenol A glucuronidation.
    Hanioka N; Naito T; Narimatsu S
    Chemosphere; 2008 Dec; 74(1):33-6. PubMed ID: 18990428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7.
    Gaiser BK; Lockley DJ; Staines AG; Baarnhielm C; Burchell B
    Xenobiotica; 2003 Nov; 33(11):1073-83. PubMed ID: 14660172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes.
    Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T
    Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II.
    Borlak J; Gasparic A; Locher M; Schupke H; Hermann R
    Metabolism; 2006 Jun; 55(6):711-21. PubMed ID: 16713428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucuronidation of a sarpogrelate active metabolite is mediated by UDP-glucuronosyltransferases 1A4, 1A9, and 2B4.
    Kim HJ; Jeong ES; Seo KA; Shin KJ; Choi YJ; Lee SJ; Ghim JL; Sohn DR; Shin JG; Kim DH
    Drug Metab Dispos; 2013 Aug; 41(8):1529-37. PubMed ID: 23704698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin.
    Xin H; Xia YL; Hou J; Wang P; He W; Yang L; Ge GB; Xu W
    J Pharm Pharmacol; 2015 Dec; 67(12):1673-81. PubMed ID: 26407805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms.
    Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N
    Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions
    Kahma H; Filppula AM; Neuvonen M; Tarkiainen EK; Tornio A; Holmberg MT; Itkonen MK; Finel M; Neuvonen PJ; Niemi M; Backman JT
    Drug Metab Dispos; 2018 Feb; 46(2):141-150. PubMed ID: 29138287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regio- and isoform-specific glucuronidation of psoralidin: evaluation of 3-o-glucuronidation as a functional marker for UGT1A9.
    Sun H; Ma Z; Lu D; Wu B
    J Pharm Sci; 2015 Jul; 104(7):2369-77. PubMed ID: 25941108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
    Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of UGTs and BCRP as potential pharmacokinetic determinants of the natural flavonoid alpinetin.
    Qi C; Fu J; Zhao H; Xing H; Dong D; Wu B
    Xenobiotica; 2019 Mar; 49(3):276-283. PubMed ID: 29436891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The configuration of the 17-hydroxy group variably influences the glucuronidation of beta-estradiol and epiestradiol by human UDP-glucuronosyltransferases.
    Itäaho K; Mackenzie PI; Ikushiro S; Miners JO; Finel M
    Drug Metab Dispos; 2008 Nov; 36(11):2307-15. PubMed ID: 18719240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol.
    Ohno A; Saito Y; Hanioka N; Jinno H; Saeki M; Ando M; Ozawa S; Sawada J
    Drug Metab Dispos; 2004 Feb; 32(2):235-9. PubMed ID: 14744946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
    Watanabe Y; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutual inhibition between carvedilol enantiomers during racemate glucuronidation mediated by human liver and intestinal microsomes.
    Takekuma Y; Yagisawa K; Sugawara M
    Biol Pharm Bull; 2012; 35(2):151-63. PubMed ID: 22293344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells.
    Zeng X; Shi J; Zhao M; Chen Q; Wang L; Jiang H; Luo F; Zhu L; Lu L; Wang X; Liu Z
    PLoS One; 2016; 11(11):e0166239. PubMed ID: 27832172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.